Premium
Non‐Ergot Dopamine Agonist‐Induced Sleep Attacks
Author(s) -
Ryan Melody,
Slevin John T.,
Wells Ammie
Publication year - 2000
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.20.7.724.35181
Subject(s) - ropinirole , pramipexole , dopamine agonist , dopamine , medicine , sleep (system call) , adverse effect , agonist , parkinson's disease , disease , psychology , pharmacology , dopaminergic , receptor , computer science , operating system
Two patients with Parkinson's disease received treatment with ropinirole and/or pramipexole, during which both experienced sleep attacks. These attacks may be a class effect of non‐ergot dopamine agonists. Health care professionals should be aware of the potential of these agents to cause sleep attacks and caution patients about this potentially life‐threatening adverse effect.